DK1497417T3 - E-epitoper af EphA2 antigen - Google Patents

E-epitoper af EphA2 antigen

Info

Publication number
DK1497417T3
DK1497417T3 DK03740654T DK03740654T DK1497417T3 DK 1497417 T3 DK1497417 T3 DK 1497417T3 DK 03740654 T DK03740654 T DK 03740654T DK 03740654 T DK03740654 T DK 03740654T DK 1497417 T3 DK1497417 T3 DK 1497417T3
Authority
DK
Denmark
Prior art keywords
epitopes
epha2 antigen
epha2
antigen
polynucleotide
Prior art date
Application number
DK03740654T
Other languages
Danish (da)
English (en)
Inventor
Kostas Kosmatopoulos
Pedro Alves
Original Assignee
Inst Nat Sante Rech Med
Roussy Inst Gustave
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med, Roussy Inst Gustave filed Critical Inst Nat Sante Rech Med
Application granted granted Critical
Publication of DK1497417T3 publication Critical patent/DK1497417T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK03740654T 2002-04-23 2003-04-23 E-epitoper af EphA2 antigen DK1497417T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0205048A FR2838742B1 (fr) 2002-04-23 2002-04-23 Epitopes t de l'antigene epha2
PCT/FR2003/001280 WO2003091383A2 (fr) 2002-04-23 2003-04-23 Epitopes t de l'antigene epha2.

Publications (1)

Publication Number Publication Date
DK1497417T3 true DK1497417T3 (da) 2007-06-25

Family

ID=28686278

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03740654T DK1497417T3 (da) 2002-04-23 2003-04-23 E-epitoper af EphA2 antigen

Country Status (11)

Country Link
US (1) US20060034856A1 (es)
EP (1) EP1497417B1 (es)
AT (1) ATE356867T1 (es)
AU (1) AU2003262810A1 (es)
CA (1) CA2482930C (es)
DE (1) DE60312502T2 (es)
DK (1) DK1497417T3 (es)
ES (1) ES2283791T3 (es)
FR (1) FR2838742B1 (es)
PT (1) PT1497417E (es)
WO (1) WO2003091383A2 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005012350A2 (en) 2003-07-30 2005-02-10 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Epha2 t-cell epitope agonists and uses therefor
WO2006034334A2 (en) * 2004-09-21 2006-03-30 University Of Pittsburgh Of The Commonwealth System Of Higher Education Peptide analogs capable of enhancing stimulation of a glioma-specific ctl response
WO2006084226A2 (en) * 2005-02-04 2006-08-10 Raven Biotechnologies, Inc. Antibodies that bind to epha2 and methods of use thereof
BRPI0608768B1 (pt) * 2005-05-09 2019-08-20 Vaxon Biotech Uso de um peptídio nativo para a produção de uma composição medicinal, processo para a obtenção in vitro de ctls com elevada avidez por um peptídio nativo e kit de vacinação
KR101561403B1 (ko) 2007-08-30 2015-10-16 다이이찌 산쿄 가부시키가이샤 항epha2 항체
EP2608799B1 (en) 2010-08-24 2018-12-12 University of Pittsburgh - Of the Commonwealth System of Higher Education Interleukin-13 receptor alpha 2 peptide-based brain cancer vaccines
ES2887580T3 (es) * 2012-03-19 2021-12-23 Stemline Therapeutics Inc Métodos para el tratamiento y seguimiento del estado del cáncer
PL3536334T3 (pl) 2012-05-16 2021-12-06 Stemline Therapeutics Inc. Szczepionki przeciw rakowi ukierunkowane na komórki macierzyste raka
TWI505113B (zh) * 2014-03-18 2015-10-21 Vivotek Inc 監視系統及其影像搜尋方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6323016B1 (en) * 2000-06-09 2001-11-27 Pe Corporation (Ny) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
US20040037840A1 (en) * 2000-10-27 2004-02-26 Beier Anne Mette Novel therapeutic vaccine formulations
AU2003215190A1 (en) * 2002-02-15 2003-09-09 Millennium Pharmaceuticals, Inc. Methods and compositions for treating aids and hiv-related disorders using 1414, 1481, 1553, 34021, 1720, 1683, 1552, 1682, 1675, 12825, 9952, 5816, 10002, 1611, 1371, 14324, 126, 270, 312, 167, 326, 18926, 6747, 1793, 1784, or 2045 molecules.

Also Published As

Publication number Publication date
EP1497417A2 (fr) 2005-01-19
AU2003262810A8 (en) 2003-11-10
CA2482930A1 (fr) 2003-11-06
AU2003262810A1 (en) 2003-11-10
DE60312502T2 (de) 2007-10-31
FR2838742B1 (fr) 2004-07-09
CA2482930C (fr) 2013-08-13
US20060034856A1 (en) 2006-02-16
PT1497417E (pt) 2007-06-01
FR2838742A1 (fr) 2003-10-24
DE60312502D1 (de) 2007-04-26
ES2283791T3 (es) 2007-11-01
WO2003091383A3 (fr) 2004-04-01
EP1497417B1 (fr) 2007-03-14
WO2003091383A2 (fr) 2003-11-06
ATE356867T1 (de) 2007-04-15

Similar Documents

Publication Publication Date Title
AR060998A1 (es) Anticuerpo monoclonal anti cd40 humana antagonista
CY1121632T1 (el) Η rv2386c πρωτεϊνη φυματιωσης, συνθεσεις και χρησεις αυτης
BR122018016045B8 (pt) proteína variante otimizada
CY1115147T1 (el) Εξουδετερωτικα αντισωματα που εχουν ειδικοτητα για ανθρωπινη il-17
CY1118200T1 (el) Πολυπεπτιδια, πολυνουκλεοτιδια και συνθεσεις για χρηση στη θεραπεια λανθανουσας φυματιωσης
ATE542829T1 (de) Impfstoff
DK2006301T3 (da) Peptid-baseret immuniseringsterapi til behandling af atherosklerose
CR8231A (es) Anticuerpos rg1 y uso de los mismos
BRPI0517973B8 (pt) métodos para purificar o fsh recombinante
CY1114584T1 (el) Ανασυνδυασμενα εμβολια και χρηση αυτων
ATE426412T1 (de) Adjuvante influenza-vakzine
NO963120D0 (no) Monoklonale antistoffer som binder til tumorrejeksjons-antigenforlöperen MAGE-3, rekombinant MAGE-1, og MAGE-1 avledete immunogene peptider
DK1497417T3 (da) E-epitoper af EphA2 antigen
DK1409692T3 (da) Nye peptider afledt af G-proteinet fra RSV, og anvendelse heraf i en vaccine
CY1119737T1 (el) Νεες συνθεσεις και μεθοδοι
NO20062579L (no) Preparater som omfatter melittin-avledede peptider og fremgangsmate for styrking av immunresponser mot malantigener
ATE551069T1 (de) Mucin-fusionspolypeptid-vakzine, zusammensetzungen und ihre verwendung
WO2004030616A3 (en) Ii-KEY/ANTIGENIC EPITOPE HYBRID PEPTIDE VACCINES
EA200501900A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
EA200501925A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
ES2502366T3 (es) Inducción de inmunidad tumoral por variantes de proteína de unión a folato
ATE389264T1 (de) Anfangssynchronisationssuche in einem mobilfunksystem
EA200600455A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
EA200600456A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
BR9911609A (pt) Proteìnas e genes de moraxella catarrhalis, antìgenos, anticorpos e usos